Cell and Gene Logistics

  1. Managing Operational Challenges In CAR-T Clinical Trial Logistics 3/18/2026

    Coordinating CAR-T trials means managing tight timelines, cryogenic handling, staffing gaps, and chain-of-identity risks where even small missteps can delay care.

  2. How To Select The Right Fill-Finish CDMO For Phase I–II 3/16/2026

    Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

  3. Scientific Staffing 3/16/2026

    A customizable scientific‑insourcing model delivers flexible onsite staffing, boosts lab capacity, reduces hiring burdens, and supports routine scientific work with trained professionals.

  4. Technical Field Services 3/16/2026

    A flexible technical field‑services program offers multi‑vendor laboratory instrument support, facility services, relocations, and environmental qualifications to optimize operations, reduce risk, and maintain compliance.

  5. Defragmenting The Pre‑Clinical Supply Chain 3/2/2026

    Fragmented pre‑clinical supply chains create avoidable delays and risks; unifying cryopreservation, logistics, and storage early improves consistency, reduces operational gaps, and supports smoother progression into clinical phases.

  6. Investors Trust Strong Supply Chains 3/2/2026

    Investors now value operational maturity as much as science. Early, intentional supply‑chain planning shows scalability, lowers risk, and builds confidence in reliable growth.

  7. Green Supply Chains Rarely Start With A Pledge; Target Waste Instead 2/27/2026

    Effective sustainability strategies in pharma supply chains reduce rework and overage. Three leakage points offer the most practical starting point for rooting out waste.

  8. Best Practices For Managing The Logistics And Distribution Of CGTs 2/23/2026

    Site infrastructure, formulary timelines, and storage capabilities create barriers between approval and patient access. Planning for these operational realities separates successful launches from stalled ones.

  9. U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact 2/18/2026

    Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

  10. Active Versus Passive Shipping Solutions For Clinical Shipments 2/13/2026

    Explore active and passive temperature-controlled shipping solutions and their impact on clinical trial supply, balancing cost, risk, and product integrity.